ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Malek G. Massad
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiDomenico, R. J.
Right arrow Articles by Massad, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiDomenico, R. J.
Right arrow Articles by Massad, M. G.
Related Collections
Right arrow Electrophysiology - arrhythmias

Ann Thorac Surg 2005;79:728-740
© 2005 The Society of Thoracic Surgeons

Review

Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery

Robert J. DiDomenico, PharmDa, Malek G. Massad, MDb,*

a Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA
b Department of Surgery, Division of Cardiothoracic Surgery, University of Illinois at Chicago, Chicago, Illinois, USA

* Address reprint requests to Dr Massad, University of Illinois at Chicago, Division of Cardiothoracic Surgery, 840 S Wood St, CSB Ste 417 (M/C 958), Chicago, IL 60612, USA
mmassad{at}uic.edu

Postoperative atrial fibrillation is a common complication after open heart surgery; it increases morbidity, hospital stay, and costs. In an analysis of 8 large cardiac surgery trials totaling 20,193 patients, the incidence of postoperative atrial fibrillation was estimated to be 26% and ranged from 17% to 35%. We reviewed the results of 52 studies published between 1966 and 2003 that evaluated pharmacologic strategies to prevent postoperative atrial fibrillation in nearly 10,000 patients undergoing open heart operations. Supraventricular tachyarrhythmias, including atrial fibrillation, after open heart operations occurred in 29% of patients who did not receive prophylactic drugs, compared with 12% in patients who received intravenous followed by oral amiodarone, 15% in those given sotalol, 16% in those given oral amiodarone, and 19% in those given ß-blockers. Pharmacologic strategies and regimens aimed at preventing postoperative atrial fibrillation are necessary to optimize the postoperative care of patients undergoing open heart operations. Although no strategy has consistently been shown to be superior to another, the most effective approach to preventing postoperative atrial fibrillation likely involves multiple interventions. In the absence of contraindications, all patients should receive ß-blocker therapy before and after the operation. For patients with 1 or more risk factors for postoperative atrial fibrillation, regimens consisting of either sotalol (ß-blocker with class III antiarrhythmic properties) alone or ß-blockers in combination with amiodarone seem to be the safest, most effective pharmacologic strategies for preventing postoperative atrial fibrillation.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
Y. S. Choi, J. K. Shim, S. W. Hong, D. H. Kim, J. C. Kim, and Y. L. Kwak
Risk factors of atrial fibrillation following off-pump coronary artery bypass graft surgery: predictive value of C-reactive protein and transfusion requirement
Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 838 - 843.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. I. Rossman, K. Liu, G. A. Morgan, R. E. Swillo, J. A. Krueger, S. J. Gardell, J. Butera, M. Gruver, J. Kantrowitz, H. S. Feldman, et al.
The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1127 - 1133.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
P. A Howard and B. J Barnes
Potential Use of Statins to Prevent Atrial Fibrillation After Coronary Artery Bypass Surgery
Ann. Pharmacother., February 1, 2008; 42(2): 253 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. R. Zebis, T. D. Christensen, I. S. Kristiansen, and V. E. Hjortdal
Amiodarone Cost Effectiveness in Preventing Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
Ann. Thorac. Surg., January 1, 2008; 85(1): 28 - 32.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
S. Gunaydin, K. Ayrancioglu, E. Dikmen, K. Mccusker, V. Vijay, T. Sari, T. Tezcaner, and Y. Zorlutuna
Clinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohorts
Perfusion, July 1, 2007; 22(4): 279 - 288.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. R. Zebis, T. D. Christensen, H. F. Thomsen, M. M. Mikkelsen, L. Folkersen, H. T. Sorensen, and V. E. Hjortdal
Practical Regimen for Amiodarone Use in Preventing Postoperative Atrial Fibrillation
Ann. Thorac. Surg., April 1, 2007; 83(4): 1326 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. J. Barnes, E. A. Kirkland, P. A. Howard, D. W. Grauer, M. E. Gorton, J. B. Kramer, G. F. Muehlebach, and W. A. Reed
Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1332 - 1337.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.